Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience
Manousos M. Konstadoulakis(National and Kapodistrian University of Athens), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Ilias P. Gomatos(Hippocration General Hospital), Maria-Isabell Fiel(Mount Sinai Medical Center), Charles M. Miller(Great Ormond Street Hospital for Children NHS Foundation Trust), Daniel M. Labow(Danbury Hospital), Sasan Roayaie(White Plains Hospital)
Cited by 86
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k